HomeCNTA • NASDAQ
add
Centessa Pharmaceuticals PLC - ADR
Previous close
$13.43
Day range
$12.74 - $13.45
Year range
$8.46 - $19.09
Market cap
1.74B USD
Avg Volume
1.07M
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 15.00M | — |
Operating expense | 45.78M | 26.84% |
Net income | -26.14M | 31.31% |
Net profit margin | -174.23 | — |
Earnings per share | -0.20 | 47.37% |
EBITDA | -30.56M | 14.76% |
Effective tax rate | -5.65% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 284.50M | 23.60% |
Total assets | 527.84M | 60.84% |
Total liabilities | 141.60M | 25.30% |
Total equity | 386.25M | — |
Shares outstanding | 133.62M | — |
Price to book | 4.65 | — |
Return on assets | -13.93% | — |
Return on capital | -15.03% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -26.14M | 31.31% |
Cash from operations | -57.25M | -53.53% |
Cash from investing | -222.39M | -1,426.74% |
Cash from financing | 3.09M | -70.59% |
Net change in cash | -278.06M | -2,733.93% |
Free cash flow | -55.74M | -132.46% |
About
Founded
2020
Website
Employees
86
